p53 induces TAP1 and enhances the transport of MHC class I peptides

Oncogene

Volumn 18, Issue 54, 1999, Pages 7740-7747

  Zhu, Kuichun ^a   Wang, Jian ^a   Zhu, Jianhui ^a   Jiang, Jieyuan ^a   Shou, Jiang ^a   Chen, Xinbin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Interferon g; MHC class I; p53; TAP1; Tumor surveillance

Indexed keywords

CARRIER PROTEIN; DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN P53; PROTEIN P73;

ANTIGEN PRESENTATION; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN TRANSPORT;

EID: 0033576618     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203235     Document Type: Article

References (47)

1. Almog N and Rotter V. (1998). Biochim. Biophys. Acta., 1378, R43-R54.
2. Alpan RS, Zhang M and Pardee AB. (1996). Cancer Res., 56, 4358-4361.
3. Amiot L, Onno M, Lamy T, Dauriac C, Le Prise PY, Fauchet R and Drenou B. (1998). Br. J. Haematol., 100, 655-663.
4. Beck S, Kelly A, Radley E, Khurshid F, Alderton RP and Trowsdale J. (1992). J. Mol. Biol., 228, 433-441.
5. Chen HL, Gabrilovich D, Tampe R, Girgis KR, Nadaf S and Carbone DP. (1996a). Nat. Genet., 13, 210-213.
6. Chen X. (1991). Mol. Med. Today 5, 387-392.
7. Chen X, Bargonetti J and Prives C. (1995). Cancer Res., 55, 4257-4263.
8. Chen X, Farmer G, Zhu H, Prywes R and Prives C. (1993). Genes Dev., 7, 1837-1849.
9. Chen X, Ko LJ, Jayaraman L and Prives C. (1996b). Genes Dev., 10, 2438-2451.
10. Cheng NC, Chan AJ, Beitsma MM, Speleman F, Westerveld A and Versteeg R. (1996). Hum. Mol. Genet., 5, 309-317.
11. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJ and Walboomers JM. (1994). J. Exp. Med., 179, 335-340.
12. D'Urso CM, Wang ZG, Cao Y, Tatake R, Zeff RA and Ferrone S. (1991). J. Clin. Invest., 87, 284-292.
13. Deiss LP and Kimchi A. (1991). Science, 252, 117-120.
14. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. (1992). Nat. Genet., 1, 45-49.
15. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
16. Gobin SJ, Peijnenburg A, Keijsers V and van den Elsen PJ. (1997). Immunity., 6, 601-611.
17. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B. (1997). Mol. Cell., 1, 3-11.
18. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
19. Johansen FE and Prywes R. (1994). Mol. Cell. Biol., 14, 5920-5928.
20. Johnsen A, France J, Sy MS and Harding CV. (1998). Cancer Res., 58, 3660-3667.
21. Jost CA, Marin MC and Kaelin Jr WG. (1997). Nature, 389, 191-194.
22. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
23. Kaklamanis L, Leek R, Koukourakis M, Gatter KC and Harris AL. (1995). Cancer Res., 55, 5191-5194.
24. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ and Schreiber RD. (1998). Proc. Natl. Acad. Sci. USA, 95, 7556-7561.
25. Khanna R, Busson P, Burrows SR, Raffoux C, Moss DJ, Nicholls JM and Cooper L. (1998). Cancer Res., 58, 310-314.
26. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
27. Levine AJ. (1997). Cell, 88, 323-331.
28. Ma W, Lehner PJ, Cresswell P, Pober JS and Johnson DR. (1997). J. Biol. Chem., 272, 16585-16590.
29. Martin BK, Chin KC, Olsen JC, Skinner CA, Dey A, Ozato K and Ting JP. (1997). Immunity, 6, 591-600.
30. McMichael A. (1998). Cell, 93, 673-676.
31. Meyer TH, van Endert PM, Uebel S, Ehring B and Tampe R. (1994). FEBS Lett., 351, 443-447.
32. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC. (1994). Oncogene, 9, 1799-1805.
33. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R. (1989). J. Virol., 63, 4417-4421.
34. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
35. Old LJ and Chen YT. (1998). J. Exp. Med., 187, 1163-1167.
36. Pamer E and Cresswell P. (1998). Annu. Rev. Immunol., 16, 323-358.
37. Ploegh HL. (1998). Science, 280, 248-253.
38. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B. (1997). Nature, 389, 300-305.
39. Proffitt JA and Blair GE. (1997). FEBS Lett., 400, 141-144.
40. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA and Bennink JR. (1993a). J. Exp. Med., 177, 265-272.
41. Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F and Rosenberg SA. (1993b). J. Immunother., 14, 182-190.
42. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD. (1998). Annu. Rev. Biochem., 67, 227-264.
43. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ and Ferrone S. (1998). Cancer Res., 58, 737-742.
44. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
45. Wang Z, Seliger B, Mike N, Momburg F, Knuth A and Ferrone S. (1998). Cancer Res., 58, 2149-2157.
46. Zhu J, Jiang J, Zhou W and Chen X. (1998a). Cancer Res., 58, 5061-5065.
47. Zhu J, Zhou W, Jiang J and Chen X. (1998b). J. Biol. Chem., 273, 13030-13036.